You are here: Industry Insights > GMP

News List

AbCellera to Build Antibody Manufacturing Facility in Canada contractpharma
June 24, 2021
AbCellera has unveiled plans for the construction of a Good Manufacturing Practices (GMP) manufacturing facility in Vancouver for the production of therapeutic antibodies, which will be the first of its kind in Canada.
Health Ministry, WHO, JSS AHER, IPA and partners organise series of virtual workshops on GMP expresspharma
June 17, 2021
The third of a series of six virtual workshops on current Good Manufacturing Practices was inaugurated by Dr Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, Government of India.
Frontera Therapeutics Starts GMP Manufacturing Facility Construction prnasia
June 16, 2021
On June 9, 2021, Frontera Therapeutics Co., Ltd. held a groundbreaking ceremony to start the construction of its Suzhou facility in bioBAY of Suzhou Industrial Park (SIP), Jiangsu, China. President of Suzhou Frontera, Dr. Xinyan Li, hosted the leaders ...
VIVEbiotech Launches Lentiviral Vectors Mfg. Plant contractpharma
June 07, 2021
VIVEbiotech, S.L., a gene transfer technologies CDMO developing and manufacturing lentiviral vectors, is opening new facilities for the manufacture of lentiviral vectors for the cell and gene therapy sector.
120 days to make, test and release each Covaxin batch: Bharat Biotech expresspharma
May 31, 2021
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP. There is a four-month lag time for Covaxin to translate into actual vaccination, a statement by the company said.
Cambrex completes GMP manufacturing expansion in Estonia firstwordpharma
May 31, 2021
The expansion will accelerate the progression and tech transfer of projects within the early clinical development phases
Cambrex Adds Kilogram-Scale Mfg. Capabilities at Estonia contractpharma
May 27, 2021
Cambrex completed an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale lab for the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) conditions.
Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Me prnasia
May 25, 2021
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products of ...
CanSino Biologics Gets OGYÉI GMP Certificate for COVID Vax contractpharma
May 25, 2021
CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI).
CordenPharma Colorado Continues Expansion contractpharma
May 14, 2021
In the fourth quarter of 2020 CordenPharma announced both an expansion of non-GMP capacity at its Center of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in upstream capacity with the introduction of a new ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page